A combination of two potential drugs gives hope of a ‘super blockage’ of an over-active immune system, Leiden researchers report in Nature. The breakthrough came from the crystallisation of a membrane protein.
Over-alert immune system
Our immune system is intended to protect the body against infiltrators. But sometimes it behaves too alertly, attacking the body itself. This results in chronic inflammation, such as multiple sclerosis, rheumatism or osteoarthritis.
Inhibiting inflammatory reactions
Laura Heitman, Ad IJzerman, Henk de Vries and Natalia Ortiz Zacarias from the Leiden Academic Centre for Drug Research (LACDR) are publishing their research this week in the journal Nature, research that may lead to a more effective way of inhibiting these responses. Their research focuses on the CCR2 receptor. The Leiden researchers work closely with an American team headed by Tracy Handel and Irina Kufureva.
Keyhole at nanoscale
A receptor is a kind of keyhole at nanoscale on the outside of a cell – in the cell membrane – into which a specific key molecule fits. The immune system comprises all kinds of immune cells, each with different types of receptors. The key molecules are called chemokines, and are produced by cells in diseased tissue. Immune cells are attracted automatically towards higher concentrations of chemokine, which generally means towards parts of the body where they are needed.
But patients with rheumatism or osteoarthritis produce too much CCL2, the chemokine for the CCR2 receptor. Although there are ways of blocking the CCR2 receptor, which in turn inhibits the inflammation, the inhibitors currently available prove to be largely ineffective in humans.
In order to discover how this process works at atomic level, Heitman and her colleagues examined the CCR2 protein using X-rays. This cannot be done using whole cells or a fragment of the cell membrane, where other proteins are also present. The researchers needed to have the CCR2 protein in very pure crystal form. This had never previously been done successfully. Laura Heitman: ‘If you take this kind of protein from the cell membrane, it’s very difficult to crystallise it.’
Thanks to this advance, researchers now have a detailed understanding of the three-dimensional form of the CCR2 protein, which is a good starting point for further research on the interaction beteween CCR2 and the related CCL2 chemokine.The research had immediate results: crystallisation was only possible if two inhibitors (BMS-681 and CCR2-RA-[R]) are both added to the CCR2 protein.
Possible duo medicine
Heitman: ‘This suggests a new strategy: duo therapy. By administering these two substances at the same time, you get a kind of “super blockage” of the CCR2 receptor, which is more effective than administering the two substances separately.’ Heitman refers to these substances deliberately as ‘potential medicines’: this is just the start of a process that could lead to a new duo medicine.
Heitman’s group will first continue their work with other receptors, CCR1 and CCR3 up to and including CCR9 before considering other super inhibitors. The ultimate aim is to manipulate the immune system so effectively that it only has beneficial effects, and the detrimental effects are excluded.
Learn more: Two-pronged attack on infectious diseases
Receive an email update when we add a new IMMUNE SYSTEM article.
The Latest on: Overactive immune system
via Google News
The Latest on: Overactive immune system
- Ribon Therapeutics Announces Dosing of First Patient in Phase 1 Clinical Trial of RBN-2397, a First-In-Class PARP7 Inhibitoron September 4, 2019 at 10:24 am
PARP7 is a Novel Tumor Dependency, Enabling Cancer Cells to Evade the Immune System First Ever Clinical ... is focused on inhibiting overactive PARP7 in tumors, which has been shown to play ...
- New CAR T-cell therapy for leukemia associated with fewer harmful side effectson September 4, 2019 at 6:19 am
Patients receiving CAR T therapies often experience CRS as the immune system becomes overactive attempting to fight the cancer cells. It can cause patients to be admitted to intensive care and can ...
- Achillion Has Multiple Shots On Goal In The Complement Spaceon August 27, 2019 at 1:07 pm
The con though is that you are seeing overactive pathways still producing lots of protein fragments that could cause damage and you are seeing a compromised immune system overall as the final ...
- What You Need to Know About Psoriasison August 26, 2019 at 12:10 am
Psoriasis is a chronic and recurrent inflammatory skin condition caused by an overactive immune system. Incidence of psoriasis occurs with equal frequency in men and woman. Mean age of onset is 27 ...
- New Method for Tackling Stroke Restrains an Overactive Immune Systemon July 2, 2019 at 3:16 pm
The pathology of a stroke is deceptively complicated. In the simplest sense, strokes occur when the blood supply to a particular region of the brain is interrupted, cutting off the area to oxygen and ...
- New knowledge on the development of asthmaon June 25, 2019 at 5:00 pm
In asthma, the immune system is overactive, causing inflammation in the lungs and symptoms such as coughing, wheezing and shortness of breath. A kind of immune T cell called a Th2 cell plays a vital ...
- Overactive Innate Immunity Tied to Higher Stroke Riskon June 18, 2019 at 2:00 pm
"As the markers increase over time, it increased risk...and this represents an overactive immune system." In contrast, higher lymphocyte counts conferred a decreased risk (HR, 0.89; 95% CI, 0.66 – ...
- How to quell a cytokine storm: New ways to dampen an overactive immune systemon May 29, 2019 at 4:07 pm
BRCA DNA-repair proteins interact with a molecular complex that is also responsible for regulating the immune system. When certain players in this pathway go awry, autoimmune disorders arise. An ...
- How to quell a cytokine storm: New ways to dampen an overactive immune systemon May 29, 2019 at 10:02 am
BRCA—the family of DNA-repair proteins associated with breast, ovarian prostate, and pancreatic cancers—interacts with a multipart, molecular complex that is also responsible for regulating the immune ...
via Bing News